The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease
Open Access
- 4 October 2015
- journal article
- research article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2015, 1-11
Abstract
Objectives. To assess zinc (Zn) and vitamin D (Vit. D) status in chronic Hepatitis C virus- (HCV) infected patients and their relationship to interleukin- (IL-) 17 and disease severity and then investigate whether Zn and Vit. D3 modulate IL-17 expression in chronic HCV patients.Methods. Seventy patients and fifty healthy subjects were investigated. Serum levels of Zn, Vit. D, and IL-17 were assessed in the patients group and subgroups. Patients lymphocytes were activatedin vitroin the presence or absence of Zn or Vit. D3 and then intracellular IL-17 production was assessed using flow cytometry.Results. Zn and Vit. D were significantly decreased in HCV patients. Increasing disease severity leads to more reduction in Zn level opposed by increasing IL-17 level. Zn potently reduced IL-17 production in a dose-related fashion; however it did not exert any toxic effects. Although Vit. D apparently increases IL17 expression, it is unclear whether it is due to its toxic effect on cell count or lack of definite association between Vit. D and both IL-17 and disease severity.Conclusions. This study demonstrates that Zn modulates IL-17 expression and provides a rationale for evaluating this compound as a supplementary agent in the treatment of chronic HCV.Keywords
This publication has 54 references indexed in Scilit:
- Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus EgyptiansWorld Journal of Hepatology, 2012
- Vitamin D deficiency: Correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4World Journal of Gastroenterology, 2012
- Combined effect of 25‐OH vitamin D plasma levels and genetic Vitamin DReceptor (NR 1I1) variants on fibrosis progression rate in HCV patientsLiver International, 2011
- 1,25-Dihydroxyvitamin D 3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17AMolecular and Cellular Biology, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology and Infection, 2011
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IJournal of Experimental Medicine, 2010
- Prevalence of Vitamin D Deficiency in Chronic Liver DiseaseDigestive Diseases and Sciences, 2009
- Perinatal Outcomes, Including Mother‐to‐Child Transmission of HIV, and Child Mortality and Their Association with Maternal Vitamin D Status in TanzaniaThe Journal of Infectious Diseases, 2009
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007